(Press-News.org) An Australian study of identical twins shows that a rare genetic form of epilepsy can be caused by a genetic mutation that occurs in the embryo, and not necessarily passed down from parents.
The study was led by the University of Melbourne and Austin Health and published in the New England Journal of Medicine.
Professor Berkovic, Director of the Comprehensive Epilepsy Program at Austin Health and Epilepsy Research Centre at the University of Melbourne and lead investigator on the study said this is an exciting finding revealing how a mutation in the embryo can cause genetic epilepsy to occur.
"While this study focused on an uncommon form of epilepsy, this finding may have implications for those with other forms of genetic epilepsy, and in fact, other types of genetic disease," Professor Berkovic said.
While this discovery was made by studying a limited group of people - those who have an identical twin with a particular form of epilepsy known as Dravet's syndrome – researchers believe it could have wider implications for siblings of people with other genetic diseases that could be caused by genetic mutation in an embryo rather than in the germ (sperm or egg) cells of the parents.
Researchers have previously believed that new mutations for epilepsy and other diseases usually occur in the sperm or egg cells of the parents, but, by using identical twins, the study shows that mutation may occur shortly after fertilisation.
If a test could be developed in the future to verify that there has been no mutation in the germ cells of the parents, siblings of a child with a disease caused by a genetic mutation could rule out the likelihood of passing it on to their own children.
"This really shows the value of studying identical twins to make genetic discoveries that are otherwise effectively invisible to scientists when studying other members of the population," Professor Berkovic said.
INFORMATION:
The study was conducted in collaboration with the Epilepsy Research Program, SA, Pathology at Women's and Children's Hospital, North Adelaide, SA, and the National Center for Adult Stem Cell Research, Griffith University QLD.
Twins provide clue that genetic epilepsy can originate in the embryo
2010-10-01
ELSE PRESS RELEASES FROM THIS DATE:
Glutamate and dopamine: Biological predictors of the transition to psychosis?
2010-10-01
Philadelphia, PA, 30 September, 2010 - There is growing evidence that two neurotransmitters - dopamine and glutamate - are abnormal in people with psychotic illness, including schizophrenia. Among many other things, these chemicals play a role in cognitive functions, such as memory, learning, and problem-solving.
A new study in Biological Psychiatry is now the first to examine the relationship between these two brain chemicals by measuring both in the same individuals.
Dr. James Stone and colleagues studied people with sub-threshold psychotic symptoms, who were at ...
Brain chemical finding could open door to new schizophrenia drugs
2010-10-01
New research has linked psychosis with an abnormal relationship between two signalling chemicals in the brain. The findings, published in tomorrow's edition of the journal Biological Psychiatry, suggest a new approach to preventing psychotic symptoms, which could lead to better drugs for schizophrenia.
Schizophrenia is one of the most common severe mental health conditions. Sufferers experience symptoms of psychosis – an inability to distinguish between reality and imagination – such as hallucinations and delusions. The condition tends to begin in the late teens or twenties, ...
Scientists discover a new way our bodies control blood pressure: the P450-EET system
2010-10-01
If you are one of the millions of Americans with high blood pressure, more help is on the way. That's because a new research study published in the October 2010 print issue of The FASEB Journal (http://www.fasebj.org) shows that a protein, called P450, metabolizes arachidonic acid in our blood vessel walls to create a tiny molecule with a big name—epoxyeicosatrienoic acid (EET)—which in mice, turns off genes responsible for vascular inflammation and ultimately relaxes blood vessels to lower blood pressure. This protein and genes are also present in humans.
"We hope these ...
Scientists define molecular on-off switches for cancer and autoimmunity
2010-10-01
A new report published in the October 2010 print issue of The FASEB Journal (http://www.fasebj.org) offers a ray of hope in the search for new cancer drugs. By examining the seemingly conflicting roles of how oncogenes and tumor suppressor genes handle cellular stress, scientists from the Institute for Advanced Studies in New Jersey argue that each of these opposing systems could be potent drug targets in the effort to stop cancer. In addition, their hypothesis provides new insights into what contributes to immunological disorders such as chronic inflammation and autoimmune ...
Scientists reveal important clues to how bacteria and viruses are identified as enemies
2010-10-01
A new research report in the October 2010 print issue of the Journal of Leukocyte Biology (http://www.jleukbio.org) sheds important light on how our immune systems detect invading organisms to be destroyed and removed from our bodies. The information from this research should ultimately help lead to the development of new drugs and treatments that allow health care providers to prevent runaway immune reactions that can have devastating consequences for people.
"Our study helps us to understand exactly how the immune system is activated when it comes across infection ...
Statement: Study finds genital herpes vaccine ineffective in women
2010-10-01
An experimental vaccine intended to prevent genital herpes disease in women, although generally safe and well-tolerated, proved ineffective when tested in the recently concluded clinical study known as the Herpevac Trial for Women.
The Phase 3 trial, sponsored by GlaxoSmithKline (GSK) Biologicals, based in Belgium, with support from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, began in 2002. A total of 8,323 women aged 18-30 years participated in the trial at 50 sites in the United States and Canada. At ...
Age 50 as mammography screening threshold proven unfounded
2010-10-01
The landmark breast cancer screening study of women 40-49, published online in Cancer, has proven that annual mammography screening of women in their 40s reduces the breast cancer death rate in these women by nearly 30 percent. The results of this largest study ever conducted on women in this age group confirm that the use of the age of 50 as a threshold for breast cancer screening is scientifically unfounded. Women should begin getting annual mammograms at age 40.
"This study, which looked at the performance of screening mammography as it is actually used, rather than ...
Why do some dialysis centers have higher survival rates?
2010-10-01
Characteristics such as patient engagement, physician communication, and staff coordination may help to explain why some dialysis centers achieve higher patient survival rates than others, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
"The purpose of this study was simple: to figure out what top-performing dialysis units might be doing differently from bottom-performing units, and to translate those findings into a blueprint for action," comments Brennan M.R. Spiegel, MD, MSHS (VA Greater Los ...
Epigenomics discovery yields new information about fat cells
2010-10-01
BOSTON –By creating a "map" of histone modifications in fat cells, investigators have discovered two new factors that regulate fat formation, a key step on the road to better understanding obesity, diabetes and other metabolic disorders. Led by investigators at Beth Israel Deaconess Medical Center (BIDMC) and the Broad Institute, the study appears in the October 1 issue of the journal Cell.
"These findings help to demonstrate the power of epigenomic mapping when it comes to gleaning key insights into fat cell formation," explains senior author Evan Rosen, MD, PhD, an ...
Poor kidney function linked to future heart and brain problems
2010-10-01
People with impaired kidney function are at a higher risk of future stroke than people with normal kidney function, concludes a study published on bmj.com today.
A second study, also published today, finds that even the earliest stages of chronic kidney disease are linked to a higher risk of coronary heart disease.
This study suggests that considering signs of early kidney disease, in addition to routinely measured risk factors such as blood pressure and blood cholesterol, modestly improves the identification of people at high risk of cardiovascular disease. It provides ...